- Home
- IPSC vs RDCM Comparison
IPSC vs RDCM Comparison
Compare IPSC & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPSC | RDCM |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 205.7M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | IPSC | RDCM |
|---|---|---|
| Price | $2.33 | $11.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $3.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 976.3K | 93.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.07 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $6,589,000.00 | N/A |
| Revenue This Year | $1,590.09 | $11.50 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | $20.64 | ★ $16.35 |
| Revenue Growth | ★ 194.81 | N/A |
| 52 Week Low | $0.34 | $9.88 |
| 52 Week High | $2.71 | $15.14 |
Technical Indicators
Market Signals| Indicator | IPSC | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 40.65 |
| Support Level | $0.49 | $10.64 |
| Resistance Level | $2.71 | $13.65 |
| Average True Range (ATR) | 0.19 | 0.68 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 79.33 | 27.76 |
Price Performance
Historical ComparisonAbout IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.